Intuitive Surgical's recovery continued Tuesday as the robotic surgery giant crushed quarterly forecasts, leading ISRG stock to near $1,000.
In this article, we discuss the 10 stocks Reddit’s WallStreetBets is buying for post-earnings gains. If you want to skip our detailed analysis of these stocks, go directly to Reddit’s WallStreetBets is Buying these 5 Stocks for Post-Earnings Gains. Retail investors who use internet forums like Reddit and StockTwits to outline their market strategy have […]
The business development company said it is planning to buy a small bank and convert itself to a bank holding company.
Shares of Nvidia (NASDAQ: NVDA) climbed by as much as 2% on Tuesday morning after a couple of Wall Street analysts raised their price targets on the company. J.P. Morgan analyst Harlan Sur reiterated an overweight (equivalent to a buy) rating on Nvidia stock, boosting his price target from $176 to $215. All of Nvidia's operating segments are performing well, and Sur argues that the stock's premium valuation is justified.
What happened Shares of Owens & Minor (NYSE: OMI) were tumbling 9.5% lower as of 11:24 a.m. EDT on Tuesday. The decline came after the healthcare solutions company provided its second-quarter update. So what Owens & Minor reported Q2 revenue of $2.
Pinterest (NYSE: PINS) stock is catching a lot of buzz recently, but not for a good reason. As economies reopened during the quarter, folks spent less time engaging with Pinterest. Pinterest started the second quarter with 478 million MAUs.
U.S. steelmakers are posting great results and their stocks have rallied. But now is not the time to jump into this sector.
Return and risk are two sides of the same coin. Investors all want the former, while keeping down the latter – but that’s a pipe dream. Every stock comes with both, and one key to success is managing the balance. That balance can be tricky, however, as risk and return potentials usually follow a direct relationship; that is, the highest return stocks typically also come with higher risk. This makes sense, as the surest way to a high return is to find stocks with low initial share prices – for in
(CLX) stock was tumbling after the company’s earnings fell far short of analyst expectations. Clorox reported a fiscal fourth-quarter adjusted profit of 95 cents a share, missing analyst forecasts for $1.36 a share, on sales of $1.8 billion, below expectations for $1.92 billion. It said it would earn between $540 and $5.70 in fiscal 2022, well below analyst forecasts for $7.67.
The leading exhibitor's stock has shed 51% over the past two months, but there are some ways to get back on track.
Pioneer Natural Resources (NYSE: PXD) generated a gusher of cash flow during the second quarter, fueled by higher oil prices and recent acquisitions. At $1.51 per share, the inaugural payout is nearly three times its regular quarterly dividend payment of $0.56 per share. Pioneer Natural Resources produced strong second-quarter results.
Nikola reported quarterly results this morning. Here's how the stock is doing.
These top-tier growth, value, and income stocks can build investor wealth, even with the market near an all-time high.
Every investor wants an ‘in,’ some hint that will tell exactly what a stock is going to do, and when. The kind of signal that will cut through the market’s noise, and makes sense of the deluge of raw data that every company generates. Multiply that data by 10,000 publicly traded stocks, and you’ll have some idea of just how daunting the markets can be. It’s tempting to follow an expert: a Wall Street analyst, or a trading guru. They all have important contributions to make. But here, we’ll take
Ocugen's stock price has soared by more than 260% in 2021, while the S&P 500 is up just 17%. The increase has been fueled by the hope that Covaxin, the COVID-19 vaccine candidate Ocugen is co-developing with India's Bharat Biotech, will lead to significant revenue for the healthcare company. The good news is that results look promising -- Ocugen reported in July that phase 3 results showed Covaxin to be over 93% effective in preventing severely symptomatic cases of COVID-19.
(Bloomberg) -- Kiyoshi Matsuura was so worried about growing old that he started using an anti-baldness treatment as a teenager.It was an obsession that went on to define his life. The Japanese entrepreneur continued to experiment with various supplements and other products, and founded his own company dedicated to fighting the ravages of time about 12 years ago.Premier Anti-Aging Co. went public in Tokyo in October and quickly became one of Japan’s best-performing stocks. It’s more than tripled
Shares of Nvidia (Nasdaq: NVDA) stock inched up a respectable 2% as of 2:15 p.m. EDT Monday after the graphics, crypto-mining, and artificial intelligence semiconductor manufacturer announced an advance in the latter part of its business this morning. As Nvidia revealed, it is setting up a "hosted AI development hub" called the "NVIDIA Base Command Platform" to offer its customers "instant access to powerful computing infrastructure wherever their data resides." NVIDIA Base Command Platform went live in May for "early access" customers, but it is now available for anyone who wants to lease access to the company's "NVIDIA DGX SuperPOD supercomputers" month to month to accelerate their own efforts at developing and testing AI algorithms.
Jay Jacobs, SVP and Head of Research & Strategy at Global X ETFs, joined Yahoo Finance to discuss Square’s acquisition of Afterpay.
Furthermore, the case against the stock looks even stronger when investors realize that Snap still isn't profitable. The first reason Snap's premium valuation is easily justified is the social network specialist's staggering growth trajectory. The social network is also seeing impressive user growth that handily exceeds Facebook's (NASDAQ: FB) and Twitter's (NYSE: TWTR).
Shares of Advanced Micro Devices (NASDAQ: AMD) rose 13.1% in July, according to data from S&P Global Market Intelligence. AMD is outgrowing the industry; as it takes market share, reaches greater scale, and the data center becomes a larger part of the business, management sees further growth in margins, targeting gross margins above 50% in the long run, up from 48% last quarter.
Brian Sozzi and Myles Udland discuss some of Tuesday’s early earnings movers, including: shares of Under Armour rallying after boosting guidance as its athletic apparel revenue more than doubles, Clorox under pressure after missing estimates and issuing a gloomy outlook, and Simon Property Group posting an earnings beat.